1. 于金明 中国 山东第一医科大学 中国工程院院士 Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage I..
2. 徐兵河 中国 中国医学科学院 2021中国工程院院士 Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palb..
3. Oscar,Arrieta 墨西哥 Institute Nacl Cancerol Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Nega..
4. Joyce,O'Shaughnessy 美国 Baylor University Risk of Recurrence in Patients With HER2+Early-Stage Breast Cancer: Literature Analysis of Patient a..
5. William J,Gradishar 美国 Northwestern University Risk of Recurrence in Patients With HER2+Early-Stage Breast Cancer: Literature Analysis of Patient a..
6. Frederick L,Greene 美国 Carolinas Medical Center Guidelines for breast cancer management in Bosnia and Herzegovina
7. Omidi, Yadollah 美国 Nova Southeastern University Recent advances in nanoscale targeted therapy of HER2-positive breast cancer
8. Morteza,Mahmoudi 美国 Michigan State University Recent advances in nanoscale targeted therapy of HER2-positive breast cancer
9. Harold J,Burstein 美国 Harvard University Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Facto..
10. Mark R,Somerfield 美国 America Society Clinic oncology Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Facto..
11. Stephen R. D,Johnston 英国 Royal Marsden NHS Foundation Trust Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Facto..
12. Jennifer K,Litton 美国 University of Texas MD Anderson Cancer Center Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Facto..
13. Hope S,Rugo 美国 University of California-San Francisco Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Facto..
14. Masahiro,Takada 日本 University of Tokyo Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzuma..
15. Satoshi,Morita 日本 Kyoto University Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzuma..
16. Masakazu,Toi 日本 Kyoto University Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzuma..